Latest total liabilities for SWTX: $88M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
SpringWorks Therapeutics (SWTX) currently reports a total liabilities of $88M as of March 2025. That compares with $89M in the prior-year period — down 1.6% year over year. Use the charts on this page to explore SpringWorks Therapeutics's total liabilities history and peer comparisons.
SpringWorks Therapeutics's total liabilities decreased from $89M to $88M — a 1.6% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
SpringWorks Therapeutics reported $88M in total liabilities as of March 2025. That compares with $89M in the prior-year period — down 1.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $88M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SpringWorks Therapeutics, and consider following SWTX for alerts when major investors trade the stock.
SpringWorks Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $88M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SWTX with unrelated industries.